Quick Answer
Prestige Consumer Healthcare Inc. reported Operating Income Loss of $336.78 million for the year ending 2025.
- Prestige Consumer Healthcare Inc. showed a decrease of -1.7% in Operating Income Loss from 2024 to 2025.
- This data is from Prestige Consumer Healthcare Inc.'s annual report (Form 10-K), filed with the SEC on May 9, 2025.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2013: $40.46 million | Q1 2014: $44.96 million | Q2 2014: $42.80 million | Q3 2014: $46.52 million | Q4 2014: $56.99 million | Q1 2015: $61.25 million | Q2 2015: $62.51 million | Q3 2015: $69.90 million | Q4 2015: $62.64 million | Q1 2016: $65.27 million | Q2 2016: $12.21 million | Q3 2016: $71.06 million | Q4 2016: $69.29 million | Q1 2017: $53.05 million | Q2 2017: $78.96 million | Q3 2017: $75.73 million | Q4 2017: $83.89 million | Q1 2018: -$23.10 million | Q2 2018: $72.49 million | Q3 2018: $70.92 million | Q4 2018: $77.54 million | Q1 2019: -$153.45 million | Q2 2019: $71.49 million | Q3 2019: $69.35 million | Q4 2019: $76.40 million | Q1 2020: $73.92 million | Q2 2020: $80.12 million | Q3 2020: $72.90 million | Q4 2020: $73.44 million | Q2 2021: $91.34 million | Q3 2021: $78.56 million | Q4 2021: $82.59 million | Q2 2022: $87.01 million | Q3 2022: $84.38 million | Q4 2022: $87.18 million | Q2 2023: $85.19 million | Q3 2023: $88.25 million | Q4 2023: $86.83 million | Q2 2024: $72.05 million | Q3 2024: $84.34 million | Q4 2024: $91.96 million | Q2 2025: $71.76 million | Q3 2025: $79.67 million | Q4 2025: $82.49 million.
- Over the full 16 years of available data (2010 to 2025), Prestige Consumer Healthcare Inc.'s Operating Income Loss has grown by 330.0%.
- Historical annual values: Fiscal year 2025: $336.78 million | Fiscal year 2024: $342.43 million | Fiscal year 2023: -$22.42 million | Fiscal year 2022: $329.92 million | Fiscal year 2021: $297.40 million | Fiscal year 2020: $291.16 million | Fiscal year 2019: $67.50 million | Fiscal year 2018: $215.47 million | Fiscal year 2017: $205.64 million | Fiscal year 2016: $260.32 million | Fiscal year 2015: $207.56 million | Fiscal year 2014: $188.62 million | Fiscal year 2013: $191.88 million | Fiscal year 2012: $102.82 million | Fiscal year 2011: $76.15 million | Fiscal year 2010: $78.33 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: